Journals / Epilepsi / 2016 / Cilt: 22 - Sayı: 0

Autoimmune Diseases Associated with Epilepsy

Epilepsi İle İlişkili Sistemik Otoimmün Hastalıklar

Journal
Epilepsi
Pages
53–66
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we will summarize patterns of neurological involvement in systemic autoimmune diseases associated with epilepsy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Involvement of the central nervous system (CNS) during the course of systemic autoimmune diseases is not rare.
📊
Key Findings & Data:Connective tissue disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis, Behçet’s disease; granulomatous disorders such as sarcoidosis, granulomatous angitis; autoimmune bowel disorders such as inflammatory bowel and Celiac diseases; thyroid disorders such as Hashimoto and Graves diseases are best examples of the autoimmune diseases in this category.
💡
Conclusion & Impact:In this review, we will summarize patterns of neurological involvement in systemic autoimmune diseases associated with epilepsy.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Involvement of the central nervous system (CNS) during the course of systemic autoimmune diseases is not rare. Connective tissue disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis, Behçet’s disease; granulomatous disorders such as sarcoidosis, granulomatous angitis; autoimmune bowel disorders such as inflammatory bowel and Celiac diseases; thyroid disorders such as Hashimoto and Graves diseases are best examples of the autoimmune diseases in this category. Epileptic seizures may be observed in patients with and without any obvious lesions in these disorders. In this review, we will summarize patterns of neurological involvement in systemic autoimmune diseases associated with epilepsy.

Özet

Sistemik otoimmün hastalıkların seyrinde merkezi sinir sistemi (MSS) nadir olmayarak tutulmaktadır. Bu hastalıklar içinde sistemik lupus eritematozus (SLE), romatoid artrit, Behçet hastalığı gibi bağ dokusu hastalıkları, sarkoidoz, granülomatöz anjit gibi granülomatöz hastalıklar, inflamatuvar bağırsak hastalıkları, Çölyak hastalığı gibi otoimmün bağırsak hastalıkları, Hashimoto ve Graves hastalığı gibi tiroid hastalıkları vardır. Bu hastalıkların seyrinde MSS tutulumuna bağlı lezyonlara sekonder epileptik nöbetler izlenebileceği gibi SLE gibi hastalıklarda belirgin bir lezyon olmadan da epilepsi ortaya çıkabilmektedir. Bu derlemede sistemik otoimmün hastalıklarda izlenen nörolojik tutulum, epileptik olaylar temel alınarak özetlenmektedir.

🔖

Cite This Article

KÜRTÜNCÜ, M., ALTUNRENDE, B., AKMAN-DEMİR, G. (2016). Autoimmune Diseases Associated with Epilepsy. Epilepsi, Cilt: 22 - Sayı: 0, 53–66. https://ajindex.com/articles/160705

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40(9):1725. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42(4):599–608.
  2. Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003;30(5):985–92.
  3. Xuan Z, Yi D, Fu-Lin T, Fen-Chun Z. Central nervous system involvement in systemic lupus erythematosus in a hospitalbased study of 171 cases: the possible therapeutic role of intrathecal therapy. J Clin Rheumatol 1999;5(6):314–9. Aszalós Z. Neurological and psychiatric manifestations of systemic lupus erythematosus and antiphospholipid syndrome. [Article in Hungarian] Orv Hetil 2011;152(15):597–605. [Abstract] Kang EH, Shen GQ, Morris R, Metzger A, Lee EY, Lee YJ, et al. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases. Lupus 2008;17(1):21–5.
  4. Hanly JG, Robichaud J, Fisk JD. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J Rheumatol 2006;33:1553–8.
  5. Harrison MJ, Ravdin LD, Lockshin MD. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum 2006;54(8):2515–22.
  6. Kozora E, West SG, Maier SF, Filley CM, Arciniegas DB, Brown M, et al. Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. J Neurol Sci 2010;295(1-2):87–91.
  7. Levite M, Ganor Y. Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis. Expert Rev Neurother 2008;8(7):1141–60. Levite M. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren’s syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease gluta- m